BRD2 and neoplasm: Follicle Stimulating Hormone (FSH) specifically augments tumour progression during the second postnatal week of by promoting Sertoli cell proliferation, the sole testicular cell type bearing FSH receptors (Matzuk et al., 1994; Kumar et al., 1996; Haverfield et al., 2017).